Table 3.
Diagnostic performance of liver fibrosis models*
| Models | AUROC | Standard error | P value | 95% confidence interval |
|
|---|---|---|---|---|---|
| Lower bound | Upper bound | ||||
| LSM |
0.757 |
0.034 |
<0.001 |
0.690 |
0.823 |
| S index |
0.726 |
0.033 |
<0.001 |
0.662 |
0.791 |
| GPRI |
0.726 |
0.032 |
<0.001 |
0.662 |
0.789 |
| FIB-4 |
0.621 |
0.037 |
0.001 |
0.549 |
0.692 |
| APRI |
0.619 |
0.035 |
0.001 |
0.550 |
0.688 |
| API |
0.580 |
0.037 |
0.033 |
0.508 |
0.652 |
| Fibro-Q |
0.569 |
0.037 |
0.066 |
0.496 |
0.642 |
| AAR | 0.495 | 0.037 | 0.886 | 0.421 | 0.568 |
*AAR – aspartate transaminase (AST) to alanine aminotransferase (ALT) ratio; API – age-platelet (PLT) index; APRI – AST to PLT ratio index; AUROC – area under the receiver operating characteristic curve; FIB-4 – age-AST-PLT-ALT index; Fibro-Q – age-AST- international normalized ratio (INR)-PLT-ALT index; LSM – liver stiffness measurement; GPRI – γ-glutamyl transpeptidase (GGT) to PLT ratio index; S index – GGT-PLT -albumin index.